Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma.

Abstract

BACKGROUND:

Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Southeast Asia. OCCC has a more unfavourable clinical outcome due to a poor response to platinum-based chemotherapy compared with serous carcinoma. The identification of biomarkers related to the prognosis of OCCC is critically important for an improved understanding of the biology that drives OCCC progression and leads to poor outcomes. To detect differences in gene expression profiles between OCCC and high-grade serous ovarian carcinoma (HGSOC), twelve patients with OCCC and twelve patients with HGSOC were recruited in whom the pathological diagnosis was confirmed on surgically resected specimens.

RESULTS:

Compared with HGSOC, OCCC has 609 differentially expression genes, and 199 are significantly different (P < 0.05). These genes are involved in the cell cycle, apoptosis, DNA damage repair, the PI3K pathway and so on. There were 164 differentially expressed genes in the PI3K pathway. There were 35 overexpressed genes in OCCC, while there were 12 overexpressed genes in HGSOC. Among these differentially expressed genes, we found that the MET gene and the CCNE1 gene were overexpressed in OCCC and associated with a worse prognosis.

CONCLUSIONS:

In conclusion, there are many differentially expressed genes in OCCC and HGSOC, which indicates that the two kinds of tumours differ greatly in tumourigenesis and provides a theoretical basis for targeted therapy in the future. Further studies need to be performed to clarify the association of the differentially expressed genes with the unfavourable prognosis in OCCC.

• Authors: Huimei Zhou, Qian Liu, Xiaohua Shi, Yue Liu, Dongyan Cao, Jiaxin Yang
• Journal: Journal of ovarian research (J Ovarian Res) Vol. 13 Issue 1 Pg. 38 (Apr 15 2020) ISSN: 1757-2215 [Electronic] England
• PMID: 32295618 (Publication Type: Journal Article)

Topics

• Adenocarcinoma, Clear Cell (genetics, surgery)
• Adult
• Aged
• Cystadenocarcinoma, Serous (genetics, surgery)
• Female
• Gene Expression Regulation, Neoplastic
• Humans
• Middle Aged
• Ovarian Neoplasms (genetics, surgery)
• Prognosis
• Transcriptome